益气温经活血方熏蒸治疗对结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性及中医证候的影响

doi:10.3760/cma.j.issn.1007-1245.2024.20.020

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (20): 3448-3452.DOI: 10.3760/cma.j.issn.1007-1245.2024.20.020

益气温经活血方熏蒸治疗对结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性及中医证候的影响

吴昊¹ 唐星² 韩鹏宇¹ 杨振宇³ 赵参军¹ 耿碧竹¹ 吴易超¹ 郑瑾¹

¹中国人民解放军空军军医大学第二附属医院中医科，西安　710038；²陕西中医药大学附属西安中医脑病医院针灸科，西安　710068；³中国人民解放军空军军医大学第二附属医院普外科，西安　710038

收稿日期:2024-06-03 出版日期:2024-10-01 发布日期:2024-10-19
通讯作者: 郑瑾，Email：243588577@163.com
基金资助:
国家自然科学基金（81572916）；陕西省科技统筹计划（2016KTCL0316）；空军军医大学第二附属医院2021年度社会人才资助计划（2021SHRC068）；2022年度临床创新救治能力提升项目（2022TDLCTS05）

Observation on the effects of fumigation and steaming with Yiqi Wenjing Huoxue Prescription on oxaliplatin induced peripheral neurotoxicity and TCM syndromes in patients with colorectal cancer undergoing adjuvant chemotherapy after surgery

Wu Hao¹, Tang Xing², Han Pengyu¹, Yang Zhenyu³, Zhao Canjun¹, Geng Bizhu¹, Wu Yichao¹, Zheng Jin¹

¹Traditional Chinese Medicine Department, The Second Affiliated Hospital of PLA Air Force Military Medical University, Xi'an 710038, China; ²Acupuncture and Moxibustion Department, Xi'an Traditional Chinese Medicine Encephalopathy Hospital Affiliated to Shaanxi University of Traditional Chinese Medicine, Xi'an 710068, China; ³General Surgery, The Second Affiliated Hospital of PLA Air Force Military Medical University, Xi'an 710038, China

Received:2024-06-03 Online:2024-10-01 Published:2024-10-19
Contact: Zheng Jin, Email: 243588577@163.com
Supported by:
National Natural Science Foundation of China (81572916); Shaanxi Provincial Science and Technology Coordination Plan (2016KTCL0316); 2021 Social Talent Funding Plan for the Second Affiliated Hospital of Air Force Medical University (2021SHRC068); 2022 Clinical Innovation and Treatment Capacity Enhancement Project (2022TDLCTS05)

摘要/Abstract

摘要：

目的　探讨益气温经活血方熏蒸治疗对结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性及中医证候的影响。方法　本研究为随机对照试验。选取2022年3月至2024年3月在中国人民解放军空军军医大学第二附属医院中西医结合肿瘤科就诊的91例结直肠癌术后需要辅助化疗患者作为研究对象。采用随机数字表法，将患者分为治疗组46例和对照组45例。共脱落8例，最终治疗组42例，对照组41例。治疗组男23例，女19例；年龄（52.37±5.25）岁；病理分期：Ⅱ期11例，Ⅲ期31例。对照组男22例，女19例；年龄（54.21±5.23）岁；病理分期：Ⅱ期12例，Ⅲ期29例。对照组采用XELOX方案化疗［奥沙利铂（静脉滴注）联合卡培他滨（口服）］，治疗组在对照组基础上采用益气温经活血方熏蒸治疗。两组均治疗6个周期（21 d为1个周期）。比较两组周围神经毒性发生率，治疗后外周神经毒性反应分级，中医证候评分，血清炎症因子水平［超氧化物歧化酶（SOD）、神经生长因子（NGF）］。采用独立样本t检验、配对t检验、χ²检验和秩和检验。结果　第4、6周期，治疗组周围神经毒性发生率［57.1%（24/42）、66.7%（28/42）］均低于对照组［92.6%（38/41）、97.5%（40/41）］（均P<0.05）。治疗4、6个周期后，治疗组周围神经毒性反应分级均优于对照组（Z=-5.051，P<0.001；Z=-5.276，P<0.001）。治疗6个周期后，治疗组SOD［（69.63±9.11）kU/L］、NGF［（176.21±26.79）ng/L］水平均高于对照组［（55.23±8.77）kU/L、（139.24±21.78）ng/L］，中医证候评分［（6.62±1.31）分］低于对照组［（8.94±2.97）分］（均P<0.05）。结论　益气温经活血方中药熏蒸可减轻结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性，改善中医证候。

关键词:

结直肠癌, 辅助化疗, 奥沙利铂, 周围神经毒性, 炎症因子, 益气温经活血方

Abstract:

Objective　To explore the effects of fumigation and steaming with Yiqi Wenjing Huoxue Prescription on oxaliplatin induced peripheral neurotoxicity and traditional Chinese medicine (TCM) syndromes in patients with colorectal cancer undergoing adjuvant chemotherapy after surgery. Methods　This study was a randomized controlled trial. A total of 91 patients with colorectal cancer requiring adjuvant chemotherapy after surgery were selected from March 2022 to March 2024 in the Department of Traditional Chinese and Western Medicine Oncology, the Second Affiliated Hospital of PLA Air Force Military Medical University. The patients were divided into a treatment group (46 cases) and a control group (45 cases) by the random number table method. A total of 8 cases fell off, and 42 cases were finally included in the treatment group and 41 cases in the control group. There were 23 males and 19 females in the treatment group, aged (52.37±5.25) years, and the pathological staging was stage Ⅱ in 11 cases and stage Ⅲ in 31 cases. There were 22 males and 19 females in the control group, aged (54.21±5.23) years, and the pathological staging was stage Ⅱ in 12 cases and stage Ⅲ in 29 cases. The control group was treated with XELOX regimen chemotherapy [oxaliplatin (intravenous infusion) combined with capecitabine (oral)], and the treatment group was given fumigation and steaming with Yiqi Wenjing Huoxue Prescription on the basis of the control group. Both groups were treated for 6 cycles, with 21 d as a cycle. The incidence of peripheral neurotoxicity, toxicity grading, TCM syndrome score, and levels of serum inflammatory factors [superoxide dismutase (SOD) and nerve growth factor (NGF)] were compared between the two groups. Independent sample t test, paired t test, χ² test, and rank sum test were used. Results　At the 4th and 6th cycle, the incidence of peripheral neurotoxicity in the treatment group [57.1% (24/42) and 66.7% (28/42)] was lower than that in the control group [92.6% (38/41) and 97.5% (40/41)] (both P<0.05). After 4 and 6 cycles of treatment, the degree of peripheral neurotoxicity in the treatment group was better than that in the control group (Z=-5.051, P<0.001; Z=-5.276, P<0.001). After 6 cycles of treatment, the levels of SOD [(69.63±9.11) kU/L] and NGF [(176.21±26.79) ng/L] in the treatment group were higher than those in the control group [(55.23±8.77) kU/L and (139.24±21.78) ng/L], and the TCM syndrome score [(6.62±1.31) points] was lower than that in the control group [(8.94±2.97) points] (all P<0.05). Conclusion　The application of fumigation and steaming with Yiqi Wenjing Huoxue Prescription can reduce the oxaliplatin induced peripheral neurotoxicity and improve the TCM syndromes in patients with colorectal cancer undergoing adjuvant chemotherapy after surgery.

Key words:

Colorectal cancer, Adjuvant chemotherapy, Oxaliplatin, Peripheral neurotoxicity, Inflammatory factors, Yiqi Wenjing Huoxue Prescription

吴昊唐星韩鹏宇杨振宇赵参军耿碧竹吴易超郑瑾.

益气温经活血方熏蒸治疗对结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性及中医证候的影响 [J]. 国际医药卫生导报, 2024, 30(20): 3448-3452.

Wu Hao, Tang Xing, Han Pengyu, Yang Zhenyu, Zhao Canjun, Geng Bizhu, Wu Yichao, Zheng Jin.

Observation on the effects of fumigation and steaming with Yiqi Wenjing Huoxue Prescription on oxaliplatin induced peripheral neurotoxicity and TCM syndromes in patients with colorectal cancer undergoing adjuvant chemotherapy after surgery [J]. International Medicine and Health Guidance News, 2024, 30(20): 3448-3452.

参考文献

[1] Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1):47-53. DOI: 10.1016/j.jncc.2024.01.006.
[2] 吴鹏,杨鸿炜,李朝杰.经肛门内镜下黏膜剥离术治疗早期直肠癌患者的效果观察[J].国际医药卫生导报,2024,30(7):1181-1185.DOI:10.3760/cma.j.issn.1007-1245.2024. 07.025.
[3] 季圆圆.益气解毒通络方预防结直肠癌患者应用奥沙利铂所致周围神经毒性的临床研究[D].合肥:安徽中医药大学,2021.DOI:10.26922/d.cnki.ganzc.2021.000371.
[4] 邢益阳,宋仲洁,赵景芳.蠲痹活络方预防奥沙利铂引起的周围神经毒性的临床观察[J].中医药学报,2022,50(5):88-91.DOI:10.19664/j.cnki.1002-2392.220115.
[5] 冯玉,王群,袁媛.通脉汤防治奥沙利铂化疗所致周围神经毒性的临床观察[J].智慧健康,2023,9(19):133-136,141.DOI:10.19335/j.cnki.2096-1219.2023.19.033.
[6] 董媛,唐雨晨,程杰,等.奥沙利铂致外周神经毒性机制及防治方法研究进展[J].包头医学院学报,2022,38(2):89-92,96.DOI:10.16833/j.cnki.jbmc.2022.02.019.
[7] 世界中医药学会联合会肿瘤精准医学专业委员会,霍介格.化疗药物导致的周围神经病变中西医结合防治专家共识[J].中国肿瘤外科杂志,2023,15(6):521-530.DOI:10.3969/j.issn.1674-4136.2023.06.001.
[8] 汤钊猷.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:66-68.
[9] Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report: management of neuropathy in cancer[J]. J Natl Compr Canc Netw, 2009, 7 Suppl 5:S1-S26; quiz S27-S28. DOI: 10.6004/jnccn.2009.0078.
[10] 徐迪华,徐剑秋.中医量化诊断[M].南京:江苏科学技术出版社,1997:152-169.
[11] 瞿幸.中医皮肤性病学[M].北京:中国中医药出版社,2009:158-173.
[12] 黄仲羽,刘凤斌.基于多维计算机自适应测试的中医证候量化方法学探索[J].时珍国医国药,2018,29(1):234-236.DOI:10.3969/j.issn.1008-0805.2018.01.085.
[13] Cavaletti G, Marmiroli P. The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity[J]. Curr Drug Saf, 2006, 1(1):35-42. DOI: 10.2174/157488606775252656.
[14] 于源,陈丽娟,孙金芳.中西医治疗化疗药物诱导周围神经病变临床研究进展[J].世界中医药,2024,19(9):1348-1354.DOI:10.3969/j.issn.1673-7202.2024.09.023.
[15] 温钧涵,刘歆,谭松.中医外治法治疗紫杉类药物所致周围神经毒性研究进展[J].河南中医,2023,43(12):1938-1944.DOI:10.16367/j.issn.1003-5028.2023.12.0371.
[16] 赵小强,赵静,张浩波,等.黄芪甲苷的提取、分离、纯化及其药理作用的研究进展[J].华西药学杂志,2022,37(6):711-716.DOI:10.13375/j.cnki.wcjps.2022.06.025.
[17] 李雪,赵婧含,吴文轩,等.桂枝的化学成分和药理作用研究进展[J].中医药学报,2023,51(5):111-114.DOI:10.19664/j.cnki.1002-2392.230114.
[18] 邹秘,徐世军,代渊.川芎活性成分改善神经退行性疾病药理研究进展[J].环球中医药,2022,15(8):1497-1502.DOI:10.3969/j.issn.1674-1749.2022.08.043.
[19] 吕燕慧,陈威,魏艳平,等.川木香属植物的化学成分及药理作用研究进展[J].中国中药杂志,2023,48(6):1463-1482.DOI:10.19540/j.cnki.cjcmm.20220617.201.
[20] 秦聪聪,杜沁圆,展照双,等.莪术挥发油化学成分及其药理作用研究[J].中国中医基础医学杂志,2024,30(1):108-116.DOI:10.19945/j.cnki.issn.1006-3250.2024.01.032.
[21] 徐革,连娜琪,于洋,等.化疗药所致周围神经病变发生机制和治疗的研究进展[J].医学综述,2020,26(18):3601-3605,3611.DOI:10.3969/j.issn.1006-2084.2020.18.012.
[22] 马凯丽,程志祥.化学治疗导致周围神经病变的发生机制及防治进展[J].中国疼痛医学杂志,2018,24(3):218-220,224.DOI:10.3969/j.issn.1006-9852.2018.03.012.
[23] 杨宇,黄兴琳,江忠敏,等.中药红花化学成分与药理作用研究新进展[J].中华中医药学刊,2023,41(10):119-126.DOI:10.13193/j.issn.1673-7717.2023.10.024.
[24] 张燕丽,田园,付起凤,等.白芍的化学成分和药理作用研究进展[J].中医药学报,2021,49(2):104-109.DOI:10.19664/j.cnki.1002-2392.210047.
[25] 中国中西医结合疼痛学会,中国抗癌协会中西医整合专业委员会,中国中医药研究促进会.化疗所致周围神经病理性疼痛中西医诊治专家共识[J].中华肿瘤防治杂志,2021,28(23):1761-1767,1779.DOI:10.16073/j.cnki.cjcpt.2021. 23.01.
[26] 张笑天,郑晓瑛.氧化自由基清除剂超氧化物歧化酶与疾病[J].中国公共卫生,2014,30(10):1349-1352.DOI:10.11847/zgggws2014-30-10-38.
[27] 杨静,李鑫楠,金华.白介素在慢性疼痛的产生和维持中的作用[J].生命科学,2022,34(6):732-741.DOI:10.13376/j.cbls/2022083.
[28] 张佳丽,陈锋州,蔡碧玉,等.养血通络方外用防治奥沙利铂所致周围神经毒性临床研究[J].浙江中医杂志,2023,58(12):874-876.DOI:10.3969/j.issn.0411-8421.2023. 12.007.
[29] 刘然,王涤凡,高宇,等.国医大师王晞星基于"调和"法论治铂类化疗药物致周围神经病变[J].现代中医临床,2024,31(1):37-40,63.DOI:10.3969/j.issn.2095-6606.2024. 01.006.
[30] 李宇清,梅开勇,杜志强,等.肿瘤化疗神经毒性及其治疗的临床研究[J].国际医药卫生导报,2006,12(15):14-17.DOI:10.3760/cma.j.issn.1007-1245.2006.15.005.

益气温经活血方熏蒸治疗对结直肠癌术后辅助化疗患者奥沙利铂所致周围神经毒性及中医证候的影响

Observation on the effects of fumigation and steaming with Yiqi Wenjing Huoxue Prescription on oxaliplatin induced peripheral neurotoxicity and TCM syndromes in patients with colorectal cancer undergoing adjuvant chemotherapy after surgery

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	卢健王亚军宋杰. 一次性根管治疗与多次法根管治疗在牙体牙髓病患者中的疗效观察 [J]. 国际医药卫生导报, 2024, 30(7): 1111-1116.
[2]	吴鹏杨鸿炜李朝杰. 经肛门内镜下黏膜剥离术治疗早期直肠癌患者的效果观察 [J]. 国际医药卫生导报, 2024, 30(7): 1181-1185.
[3]	欧阳月仙吴海蓉彭姣周立德. 自体富血小板血浆在慢性难愈合创面治疗中的效果分析 [J]. 国际医药卫生导报, 2024, 30(6): 1013-1017.
[4]	朱运青李帆乔孝武. 肺部康复训练在沙丁胺醇治疗重度支气管哮喘急性期患儿中的效果 [J]. 国际医药卫生导报, 2024, 30(4): 544-548.
[5]	杜生旺史春强吴新军张婷婷. 腹腔镜术前口服高糖溶液对结直肠癌患者的影响 [J]. 国际医药卫生导报, 2024, 30(4): 606-609.
[6]	高永昌姚庆娟. 难治性局部晚期三阴性乳腺癌患者新辅助化疗后肿瘤异质性1例 [J]. 国际医药卫生导报, 2024, 30(4): 632-634.
[7]	闫家文卫姝岑. 不同途径营养支持方式在肾部分切除术治疗易位性肾细胞癌患者中的应用效果 [J]. 国际医药卫生导报, 2024, 30(21): 3589-3593.
[8]	陈愿赵子明崔留义马翔宇沈蕾. 达格列净联合沙库巴曲缬沙坦治疗射血分数降低心力衰竭患者的疗效与安全性 [J]. 国际医药卫生导报, 2024, 30(2): 301-305.
[9]	李冲王飞. HOPX表达与局部晚期乳腺癌新辅助化疗疗效的关系 [J]. 国际医药卫生导报, 2024, 30(19): 3296-3301.
[10]	韩佩佩杨春张平安. 光动力疗法联合他克莫司软膏治疗丘疹脓疱型玫瑰痤疮的疗效 [J]. 国际医药卫生导报, 2024, 30(16): 2747-2751.
[11]	员阳齐华光张信闫博闫亮. 术中神经电生理监测技术在脊柱手术患者中的应用价值 [J]. 国际医药卫生导报, 2024, 30(16): 2756-2760.
[12]	周井荣王刚. 地中海饮食对结直肠癌恶病质患者的效果 [J]. 国际医药卫生导报, 2024, 30(15): 2563-2569.
[13]	刘洁霍倩雯王勇. 肠内营养联合连续性血液净化对重症急性胰腺炎患者的治疗效果 [J]. 国际医药卫生导报, 2024, 30(12): 2049-2052.
[14]	赵玉军姜敏. 清热化痰散结方联合糖皮质激素对亚急性甲状腺炎患者的疗效研究 [J]. 国际医药卫生导报, 2024, 30(11): 1836-1840.
[15]	解胜华吴雪梅张玉杰. 银屑病合并代谢性疾病发病机制的研究进展 [J]. 国际医药卫生导报, 2023, 29(9): 1189-1192.